Dr. Glaucomflecken Explains: Triple-Antihypertensive Pill after Intracerebral Hemorrhage (TRIDENT) @NEJMgroup
Dr. Glaucomflecken Explains: Triple-Antihypertensive Pill after Intracerebral Hemorrhage (TRIDENT) @NEJMgroup
Uploaded June 2026 | Updated September 2026, 2 weeks ago
Blood-pressure reduction is the only proven treatment to prevent stroke due to intracerebral hemorrhage.

This video in our partnership with @DGlaucomflecken explains a randomized trial evaluating the efficacy and safety of a triple-antihypertensive pill after intracerebral hemorrhage.

View the Original Article for free: https://nej.md/DrG43

#neurology #medicaleducation #NEJM
Dr. Glaucomflecken Explains: Triple-Antihypertensive Pill after Intracerebral Hemorrhage (TRIDENT)Intention to Treat: The Race Equation (Audio Preview)Review Article: Antidotes for Anticoagulation Reversal (Key Points)Leading Transformation in Rural Health: How Mayo Clinic Health System Is Redefining Care, Culture...NEJM Interview: Jatin Vyas on the effect of corporatization of academic medical centers on medica...Images in Clinical Medicine: Vibrio vulnificus Necrotizing Soft-Tissue InfectionImage Challenge β€” April 23, 2026Intention to Treat: When Race Matters (Promo)Are E-Cigarettes Really Safe?When No Ones WatchingImage Challenge β€” August 13, 2026NEJM Interview: Amy Stimpfel on a new policy that would cap loans for graduate nursing and other ...
NEJM Group |

Dr. Glaucomflecken Explains: Triple-Antihypertensive Pill after Intracerebral Hemorrhage (TRIDENT)

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER